Compare AAL & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AAL | BIO |
|---|---|---|
| Founded | 1930 | 1952 |
| Country | United States | United States |
| Employees | 133700 | 7450 |
| Industry | Air Freight/Delivery Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6B | 7.1B |
| IPO Year | 2004 | N/A |
| Metric | AAL | BIO |
|---|---|---|
| Price | $11.14 | $278.65 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 4 |
| Target Price | $15.84 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 71.8M | 276.2K |
| Earning Date | 04-23-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.17 | N/A |
| Revenue | ★ $54,633,000,000.00 | N/A |
| Revenue This Year | $10.80 | $2.74 |
| Revenue Next Year | $5.27 | $3.05 |
| P/E Ratio | $63.15 | ★ $9.72 |
| Revenue Growth | ★ 0.78 | N/A |
| 52 Week Low | $8.50 | $211.43 |
| 52 Week High | $16.50 | $343.12 |
| Indicator | AAL | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 46.19 | 54.30 |
| Support Level | $10.99 | $256.85 |
| Resistance Level | $11.34 | $289.61 |
| Average True Range (ATR) | 0.41 | 7.89 |
| MACD | 0.13 | 2.09 |
| Stochastic Oscillator | 82.73 | 81.41 |
American Airlines is the world's largest airline by aircraft, capacity, and scheduled revenue passenger miles. Its major US hubs are Dallas/Fort Worth, Charlotte, Chicago, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C. It generates over 30% of US airline revenue connecting Latin America with destinations in the United States. After completing a major fleet renewal, the company has the youngest average fleet of US legacy carriers.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.